Description
Overview
Activates PPAR-delta increasing fatty-acid oxidation and endurance; commonly mislabeled as a SARM.
Composition / Profile
- Active compound: GW-501516 (Cardarine)
- Drug class: PPAR-delta agonist (NOT a SARM)
- Pack / dose (this listing): 1000 mg
Format
- Oral capsule/tablet or liquid
- Pack / dose: 1000 mg
Dosage & Usage Patterns
- Bodybuilding (commonly cited): Commonly cited: ~10–20 mg/day; often run 8–12 weeks for endurance phases.
- Clinical / general reference: No established human dose; research compound.
- Half-life: ~20-24 h (reported).
- Protocols vary by individual, compound stack, and bloodwork — figures above reflect community-reported patterns, not medical recommendations.
Effects
Reported benefits (commonly cited)
- Endurance and fatty-acid oxidation improvement reported.
- No hormonal suppression.
- Often stacked in cutting phases.
Reported side effects
- No direct hormonal suppression, but the key concern is carcinogenicity.
Key Interactions
- PPAR pathway.
- Not androgen-receptor active.
Precautions
- Development was halted after rodent studies showed cancer across multiple organs at various doses — the dominant safety flag.
Common Misconception
Myth: ‘endurance with no downside.’
Evidence: the cancer signal in animal studies is why it was never approved.
Related Categories
- Browse more in SARMs → GW-501516 (Cardarine).
Storage
- Store in a cool, dry place away from direct light and moisture






Reviews
There are no reviews yet.